As of 2026-09-09, the Intrinsic Value of Pliant Therapeutics Inc (PLRX) is -12.06 USD. This PLRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.13 USD, the upside of Pliant Therapeutics Inc is -1,162.51%.
Based on its market price of 1.13 USD and our intrinsic valuation, Pliant Therapeutics Inc (PLRX) is overvalued by 1,162.51%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.06 - -12.06 | -12.06 | -1,162.51% |
| P/E | (74.29) - (52.82) | (66.87) | -5991.6% |
| DDM - Stable | (30.68) - (246.31) | (138.49) | -12302.1% |
| DDM - Multi | (29.52) - (186.48) | (51.18) | -4609.6% |
| Market Cap (mil) | 70.28 |
| Beta | 1.03 |
| Outstanding shares (mil) | 61.92 |
| Enterprise Value (mil) | 45.40 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.19% |
| Cost of Debt | 5.00% |
| WACC | 5.43% |